What is the official website of Novartis Gulf | نوفارتس الخليج ?

The official website of Novartis Gulf | نوفارتس الخليج is https://www.novartis.com/.

What is Novartis Gulf | نوفارتس الخليج's cybersecurity risk score?

Novartis Gulf | نوفارتس الخليج has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Novartis Gulf | نوفارتس الخليج experienced?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Novartis Gulf | نوفارتس الخليج been affected by any supply chain cyber incidents ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Novartis Gulf | نوفارتس الخليج have SOC 2 Type 1 certification ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج is not certified under SOC 2 Type 1.

Does Novartis Gulf | نوفارتس الخليج have SOC 2 Type 2 certification ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج does not hold a SOC 2 Type 2 certification.

Does Novartis Gulf | نوفارتس الخليج comply with GDPR ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج is not listed as GDPR compliant.

Does Novartis Gulf | نوفارتس الخليج have PCI DSS certification ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج does not currently maintain PCI DSS compliance.

Does Novartis Gulf | نوفارتس الخليج comply with HIPAA ?

According to Rankiteo, Novartis Gulf | نوفارتس الخليج is not compliant with HIPAA regulations.

Does Novartis Gulf | نوفارتس الخليج have ISO 27001 certification ?

According to Rankiteo,Novartis Gulf | نوفارتس الخليج is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Novartis Gulf | نوفارتس الخليج operate in ?

Novartis Gulf | نوفارتس الخليج operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Novartis Gulf | نوفارتس الخليج have ?

Novartis Gulf | نوفارتس الخليج employs approximately 185 people worldwide.

Does Novartis Gulf | نوفارتس الخليج own any subsidiaries ?

Novartis Gulf | نوفارتس الخليج presently has no subsidiaries across any sectors.

How many LinkedIn followers does Novartis Gulf | نوفارتس الخليج have ?

Novartis Gulf | نوفارتس الخليج's official LinkedIn profile has approximately 23,316 followers.

What is the NAICS classification code for Novartis Gulf | نوفارتس الخليج ?

Novartis Gulf | نوفارتس الخليج is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Novartis Gulf | نوفارتس الخليج have a Crunchbase profile ?

No, Novartis Gulf | نوفارتس الخليج does not have a profile on Crunchbase.

Does Novartis Gulf | نوفارتس الخليج have a LinkedIn profile ?

Yes, Novartis Gulf | نوفارتس الخليج maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novartis-gulf.

How many cybersecurity incidents has Novartis Gulf | نوفارتس الخليج experienced ?

As of October 4, 2026, Rankiteo reports that Novartis Gulf | نوفارتس الخليج has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Novartis Gulf | نوفارتس الخليج have ?

Novartis Gulf | نوفارتس الخليج has an estimated 5,772 peer or competitor companies worldwide.

What types of cybersecurity incidents has Novartis Gulf | نوفارتس الخليج faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

Novartis Gulf | نوفارتس الخليج Vendor Cyber Rating & Cyber Score

novartis.com

Add Your Compliance Badge

Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world. See our community guidelines: https://bit.ly/LinkedInGulf

Novartis Gulf | نوفارتس الخليج CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Novartis

Breach

2/2026

NOV1774449180

Novartis Gulf | نوف...

Cyber Attack

100

06/2022

NOV21267722

Loading…

A.I.

NG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for NG

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Gulf | نوفارتس الخليج in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Novartis Gulf | نوفارتس الخليج in 2026.

Incident Types NG vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Gulf | نوفارتس الخليج in 2026.

Incident History - NG (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Novartis Gulf | نوفارتس الخليج Subsidiaries

NG

Pharmaceutical Manufacturing

Website: https://www.novartis.com/

Company Size: 185

NovartisPharmaceutical Manufacturing

Novartis IndiaPharmaceutical Manufacturing

Novartis SciencePharmaceutical Manufacturing

Novartis Gene TherapiesBiotechnology Research

Novartis BrasilPharmaceutical Manufacturing

Novartis USPharmaceutical Manufacturing

Novartis MéxicoPharmaceutical Manufacturing

Novartis EspañaPharmaceutical Manufacturing

Novartis DeutschlandPharmaceutical Manufacturing

Novartis PortugalPharmaceutical Manufacturing

Novartis ColombiaPharmaceutical Manufacturing

Novartis ItaliaPharmaceutical Manufacturing

Novartis, Australia & New ZealandPharmaceutical Manufacturing

Novartis ArgentinaPharmaceutical Manufacturing

Novartis US MedicalPharmaceutical Manufacturing

Novartis Ireland Pharmaceutical Manufacturing

Novartis CanadaPharmaceutical Manufacturing

Novartis NorgePharmaceutical Manufacturing

Novartis NederlandPharmaceutical Manufacturing

Novartis Nederland - NeurologieGeneesmiddelenproductie

Novartis Nederland - OncologieGeneesmiddelenproductie

Novartis Nederland - ReumatologieGeneesmiddelenproductie

Novartis Nederland - HematologieGeneesmiddelenproductie

Novartis Nederland - DermatologieGeneesmiddelenproductie

Novartis Nederland - Cardiovascular, Renal & Metabolism Geneesmiddelenproductie

Novartis SingaporePharmaceutical Manufacturing

Novartis in SloveniaPharmaceutical Manufacturing

Novartis BeluxPharmaceutical Manufacturing

Novartis RomâniaPharmaceutical Manufacturing

Novartis SverigePharmaceutical Manufacturing

Novartis DanmarkPharmaceutical Manufacturing

Novartis MagyarországPharmaceutical Manufacturing

Novartis SlovakiaPharmaceutical Manufacturing

Novartis Hong KongPharmaceutical Manufacturing

Novartis IsraelPharmaceutical Manufacturing

Novartis SerbiaPharmaceutical Manufacturing

Novartis FinlandPharmaceutical Manufacturing

Novartis MedicalPharmaceutical Manufacturing

Loading…

Novartis Gulf | نوفارتس الخليج Similar Companies

Cipla

cipla.com

Cipla is a leading global pharmaceutical company trusted by healthcare professionals and patients across the world since 1935. A compassionate approach to healthcare that goes beyond the pursuit of profit and growth has been the force impelling Cipla’s history over the years. Our credo and our purpose of ‘Caring for Life' continues to guide our actions towards our people and the planet for creating a sustainable future. Cipla today has presence in 80+ countries, providing over 1,500 products across various therapeutic categories in 50+ dosage forms. Keeping with our legacy of care, we constantly strive to ensure access to high-quality medicines that make a difference in the lives of patients. Our paradigm-changing offer of a triple anti-retroviral (ARV) therapy in HIV/AIDS at less than a dollar a day in Africa in 2001 was pivotal in bringing inclusiveness, accessibility and affordability to the centre of the HIV movement. An unmatched presence across the care continuum (awareness, prevention, diagnosis, treatment and adherence) and the widest range of drug-device combinations has established Cipla’s respiratory leadership in India and other key emerging markets. Armed with this legacy and a deep understanding of the lungs, we have articulated our aspiration to become a global lung leader and help millions breathe free.

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

MENARINI Group

menarini.com

The Menarini Group is a leading international pharmaceutical and diagnostics company, with 140 years of history, present in 140 countries worldwide, with a turnover of 4.88 billion euro and more than 17,000 employees. With 9 centers for Research & Development, Menarini’s products are present in the most important therapeutic areas, including cardiology, oncology, gastroenterology, pneumology, diabetes, and anti-inflammatory/analgesics. The Group’s pharmaceutical production is carried out in its 18 manufacturing plants and is distributed across six continents. Menarini’s pharmaceutical production, in line with the highest quality standards, provides an ongoing contribution to the health of patients all over the world. For further information, please visit www.menarini.com For reading our Netiquette, please visit https://www.menarini.com/en-us/data-privacy/netiquette-of-menarini-group For reading our Privacy Notice for social networks users, please visit https://www.menarini.com/en-us/data-privacy/privacy-notice-for-social-network-users-of-menarini-group

Viatris

viatris.com

Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale. In 2022 alone, we supplied high-quality medicines to approximately 1 billion patients around the world. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world’s most enduring health challenges, access takes on deep meaning at Viatris. We have the ability to touch all of life’s moments, from birth to end of life, acute conditions to chronic diseases. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India Social Media Guidelines: https://newsroom.viatris.com/social-media-community-guidelines Investors: https://investor.viatris.com Corporate Social Responsibility: https://www.viatris.com/sustainability Connect with Viatris Instagram: https://www.instagram.com/viatrisinc X: https://www.x.com/viatrisinc Viatris and our recruiting firms will not ask for sensitive personal information, such as your social security number, date of birth or bank account details via text, email or social media. Additionally, Viatris representatives do not request payment or personal bank information nor send payment to purchase hardware on your own. Viatris.com is the primary source of all company job postings and authorized third-party career websites.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

MSD

msd.com

At MSD, known as Merck & Co., Inc., Rahway, NJ, USA in the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world – and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities. For more information, visit www.msd.com and connect with us on Facebook, Instagram, Twitter, and YouTube.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

Loading…

NEWS

Novartis Gulf | نوفارتس الخليج CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96451

SUMMARY

Authorization Bypass Through User-Controlled Key vulnerability in Ultimate Member Ultimate Member ultimate-member allows Privilege Escalation.This issue affects Ultimate Member: from n/a through 2.13.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.8)

cvss3

Base Score: 8.8

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/ultimate-member/vulnerability/wordpress-ultimate-member-plugin-2-13-1-privilege-escalation-vulnerability?_s_id=cve

CVE-2026-103342

SUMMARY

Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Unlimited Elements Unlimited Elements For Elementor (Free Widgets, Addons, Templates) unlimited-elements-for-elementor allows Reflected XSS.This issue affects Unlimited Elements For Elementor (Free Widgets, Addons, Templates): from n/a through 2.0.20.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 7.1)

cvss3

Base Score: 7.1

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:L

Impact Score

3.7

Exploitability

2.8

REFERENCES

https://patchstack.com/database/wordpress/plugin/unlimited-elements-for-elementor/vulnerability/wordpress-unlimited-elements-for-elementor-free-widgets-addons-templates-plugin-2-0-20-cross-site-scripting-xss-vulnerability?_s_id=cve

CVE-2026-103065

SUMMARY

Improper Validation of Specified Quantity in Input vulnerability in Themeum Kirki kirki allows Accessing Functionality Not Properly Constrained by ACLs.This issue affects Kirki: from n/a through 6.3.1.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 8.2)

cvss3

Base Score: 8.2

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:L/A:N

Impact Score

4.2

Exploitability

3.9

REFERENCES

https://patchstack.com/database/wordpress/plugin/kirki/vulnerability/wordpress-kirki-plugin-6-3-1-arbitrary-code-execution-vulnerability?_s_id=cve

CVE-2026-105122

SUMMARY

OpenAM before 16.1.3 contains a server-side request forgery vulnerability that allows attackers able to register or modify OAuth 2.0 clients to make OpenAM fetch internal resources via an unvalidated jwks_uri. Attackers can trigger unauthenticated fetches through client-authentication and ID-token validation to probe internal hosts, metadata endpoints or local files, or exhaust request threads for denial of service.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 5.4)

cvss3

Base Score: 5.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:L

cvss4

Base Score: 5.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

2.5

Exploitability

2.8

REFERENCES

CVE-2026-105121

SUMMARY

OpenAM before 16.1.3 contains an improper authorization vulnerability that allows delegated administrators to destroy sessions outside their realms because realm checks use the requester's realm. Authenticated accounts holding the iplanet-am-session-destroy-sessions attribute can supply a target session identifier or handle to forcibly log out users in any realm.

Published

Date2026-10-03

Updated

Date2026-10-03

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:N/I:N/A:H

cvss4

Base Score: 6.9

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:H/UI:N/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.6

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Novartis Gulf | نوفارتس الخليج Vendor Cyber Rating & Cyber Score

NG A.I CyberSecurity Scoring

Novartis Gulf | نوفارتس الخليج CyberSecurity News & History

NG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for NG

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types NG vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - NG (X = Date, Y = Severity)

Novartis Gulf | نوفارتس الخليج Subsidiaries

NG

Novartis Gulf | نوفارتس الخليج Similar Companies

Cipla

Alembic Pharmaceuticals Limited

Astellas Pharma

MENARINI Group

Viatris

Novo Nordisk

Novartis

MSD

Catalent

Novartis Gulf | نوفارتس الخليج CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Novartis Gulf | نوفارتس الخليج CyberSecurity News & History

NG Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for NG

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types NG vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - NG (X = Date, Y = Severity)

Novartis Gulf | نوفارتس الخليج Subsidiaries

NG

Novartis Gulf | نوفارتس الخليج Similar Companies

Cipla

Alembic Pharmaceuticals Limited

Astellas Pharma

MENARINI Group

Viatris

Novo Nordisk

Novartis

MSD

Catalent

Novartis Gulf | نوفارتس الخليج CyberSecurity News

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo